NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

37 hedge funds and large institutions have $92.1M invested in NKGen Biotech, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.1M
2
+$10.9M
3
+$5.81M
4
FTCM
Fir Tree Capital Management
New York
+$4.84M
5
6CM
683 Capital Management
New York
+$4.84M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$13.1M
2
$10.9M
3
$5.81M
4
$4.84M
5
$4.84M
6
$4.46M
7
$3.88M
8
$3.54M
9
$3.4M
10
$3.39M
11
$2.91M
12
$2.79M
13
$2.57M
14
$2.46M
15
$2.45M
16
$2.42M
17
$1.94M
18
$1.94M
19
$1.7M
20
$1.45M
21
$1.45M
22
$1.45M
23
$1.45M
24
$973K
25
$969K
1
2